Uncategorized
Gyroscope Therapeutics Announces FDA Clearance for Orbit Subretinal Delivery System
LONDON--(BUSINESS WIRE)-- #OrbitSDS--Gyroscope announces that the U.S. Food & Drug Administration (FDA) has granted 510(k) clearance for the Orbit Subretinal Delivery System.